Age-Specific Mortality Rate for All Infectious Diseases, Both Male & Female, Years

Similar documents
Infectious Diseases At A Glance in Durham Region

Communicable Disease & Immunization

COMMUNICABLE DISEASE REPORT

Overview Existing, Emerging, and Re-Emerging Communicable Diseases

COMMUNICABLE DISEASE REPORT Quarterly Report

COMMUNICABLE DISEASE REPORT

Alberta Notifiable Disease Incidence

2016/17 Vaccination and Immunisation list of additional services and enhanced services

DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report

DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report

2017/18 Immunisation programmes list of additional and enhanced services

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector

2018/19 Immunisation programmes list of additional and enhanced services

COMMUNICABLE DISEASES EPIDEMIOLOGIC REPORT

Healthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.

Family and Travel Vaccinations

2016 Vaccine Preventable Disease Summary

2015 Vaccine Preventable Disease Summary

Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines

COMMUNICABLE DISEASE REPORT

Annual Summary of Reportable Diseases Ottawa County 2017

kernfamilyhealthcare.com. Si necesita esta información en español, por favor llámenos.

2009 Halton Region Health Department

BODY DEFENCES AGAINST DISEASE AND THE ROLE OF VACCINES

2017 Preventive Schedule

2017 Vaccine Preventable Disease Summary

Proof of residency in East Orange is mandatory (see Residency Requirements)

A. Children born in 1942 B. Children born in 1982 C. Children born in 2000 D. Children born in 2010

Communicable Disease Update; Vol. 16 (1), February 2017

NSW PUBLIC HEALTH BULLETIN

Reference: Halton Region Health Department, 2017 Annual Infectious Disease Report. Oakville, Ontario, July 2018.

HEALTH REQUIREMENTS AND SERVICES: FFAD COMMUNICABLE DISEASES (EXHIBIT) REQUIREMENTS FOR EXCLUDING STUDENTS AND REPORTING CONDITIONS

Volume. March Year End. Hepatitis. estimated. male. The. mean age of

CONTACTS & ACKNOWLEDGEMENTS

New Brunswick Communicable Disease 2015 Surveillance Annual Report

NOTIFIABLE DISEASES IN NOVA SCOTIA 2016 SURVEILLANCE REPORT

your 11- to 13-year-old and enter a raffle to win a Nintendo Wii and other great prizes visit: for more information

Annual Communicable Disease Report

Health Questionnaire

VACCINES FOR ADULTS. Developing an Underutilised Health Resource. 13 November 2007

Economic aspects of viral hepatitis in Turkey. Levent AKIN VIRAL HEPATITIS PREVENTION BOARD MEETING ISTANBUL, TURKEY, NOVEMBER 12-13, 2009

Orientation Program for Infection Control Professionals

PORCUPINE HEALTH UNIT INFECTIOUS DISEASE STATUS REPORT

PATH Quick Reference Guide: Coding for Pediatric Health HEDIS Measures

Infectious Diseases Weekly Report. 12 January 2018 / Number 1. The infectious diseases which all physicians must report

COMMUNICABLE DISEASE REPORT

Infectious Diseases Weekly Report. 23 August 2018 / Number 33. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 8 November 2018 / Number 44. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 15 November 2018 / Number 45. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 14 March 2019 / Number 10. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 22 March 2019 / Number 11. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 28 March 2019 / Number 12. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 4 April 2019 / Number 13. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report. 11 April 2019 / Number 14. The infectious diseases which all physicians must report

Manitoba Health, Healthy Living and Seniors

Public Health Wales Vaccine Preventable Disease Programme

2017 Preventive Health Care Guidelines Free preventive care to help you be your healthiest.

Vaccines for Children

Guidelines Description USPSTF HRSA CDC Benefit Description Types Ages

Young Adults (Ages 18 26)

2017 Preventive Health Care Guidelines Free preventive care to help you be your healthiest.

New Brunswick Communicable Disease 2013 Annual Report

Dear Parents. To obtain your child s immunisation history you can:

Centers for Disease Control and Prevention. Final Revised Vaccine Information Materials for MMR

Vaccinations for Adults

2017 Preventive Schedule

Appendix An Assessment Tool to Determine the Validity of Vaccine Doses

Florida Department of Health - Polk County Weekly Morbidity Report - Confirmed and Probable cases * Week #9 (through March 3, 2018)

New Brunswick Communicable Disease 2014 Annual Report

COMMUNICABLE DISEASE REPORT

Recommended Health Screenings

CHAPTER ONE: EXECUTIVE SUMMARY. The Global Vaccine Industry CHAPTER TWO: INTRODUCTION TO VACCINES

Vaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines

2018 Preventive Schedule

Communicable Diseases Report, NSW, March and April 2012

COMMUNICABLE DISEASES SURVEILLANCE SYSTEM IN BULGARIA

Early Learning Centre Immunisation Policy Legislation ACT Public Health Regulations (2000)

Infectious Diseases Weekly Report. 14 March 2013 / Number 10

Surveillance Site Reporting Requirements for Infectious Diseases

Schedule of Benefits

Vaccine-Preventable Diseases in Colorado s Children 2009 Sean O Leary MD, Carl Armon PhD, Joni Reynolds, RNC, MSN, James Todd MD

Up-to-date immunization coverage rates among 2-year olds in Saskatchewan First Nations communities

History and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8

Pediatric Quality Measure Information Sheet 2017

Grow & Stay Healthy Guidelines to Live By

Manitoba Monthly Surveillance Unit Report

Preventive care covered with no cost sharing Get checkups, screenings, vaccines, prenatal care, contraceptives and more with no out-of-pocket costs

Subject: Preventive Services Policy Effective Date: 08/2017 Revision Date: 05/2018

'Contagious Comments' Department of Epidemiology

Table Of Contents Executive Summary Introduction to Vaccines Pediatric Preventive Vaccines

Manitoba Annual Immunization Surveillance Report

Immunizations for Children and Teens with Suppressed Immune Systems

Centers for Disease Control and Prevention. Proposed Revised Vaccine Information Materials for MMR

Preventive Care Guide

Line Diagnosis 2017 Codes 2018 Codes. 3 Tuberculosis A15- through A19- A15- through A19-, O98.01-

2019 Preventive Schedule Effective 1/1/2019

The Danish childhood vaccination program SUMMARY IN ENGLISH

Preventive Services Reference Guide for Members 2018

Daycare, school entry and school program immunization report. Data for school year 2016/17

Transcription:

Per 100,000 population Health Indicators 10. Infectious Diseases 10-01. Infectious Disease Mortality Description Mortality Rate for all Infectious Diseases, by Age Group 400 Age-Specific Mortality Rate for All Infectious Diseases, Both Male & Female, 2001-2005 300 200 100 0 00-19 65-74 75+ Total* S-Rate** 1.6 2.1 9.7 50.0 331.1 28.4 21.1 1.1 3.1 13.0 44.2 331.4 26.9 21.9 * The total is presented using the crude rate *S-Rate: Age-Standardized Mortality Rate Leading Causes of Death due to Infectious Disease Leading Causes of Death due to Infectious Diseases, Both Male & Female, 2001-2005 Pneumonia Septicaemia Enteric Diseases Influenza Viral hepatitis Others 4.8% 5.0% 3.1% 3.6% 5.0% 3.2% 4.5% 0.7% 20.4% 20.1% 56.4% 63.3%

Per 1,000 population Year per 1,000 population Potential of Life Lost (PYLL)* due to Infectious Diseases 2.5 Potential of Life Lost (PYLL) due to Infectious Diseases*, 2001-2005 2.0 1.5 1.0.5.0 Male Female Both 1.7.9 1.3 1.9 1.0 1.5 *Note:The potential years of life lost (PYLL) is the number of years of life lost when a person dies from any cause before the age of 75. 10-2. Infectious Disease Morbidity Description Hospitalization Rate for All Infectious Diseases 25 20 15 10 5 Hospitalization Rate for Infectious Diseases, Both Male & Female, 2004-2008 0 0-4 05-09 10-19 years 65-74 75+ Total* S-Rate** 13.8 3.1 1.0 0.9 2.2 6.4 20.0 3.8 3.4 9.0 1.8 0.8 0.9 2.0 5.8 18.0 3.0 2.8 * The total is presented using the crude rate *S-Rate: Age-Standardized Mortality Rate

Days per Patient Average Length of Stay in Hospital (Day/per patient) due to Infectious Diseases 12 Average Length of Stay in Hospital due to Infectious Diseases, 2004-2008 8 4 0 0-4 05-09 10-19 years 65-74 75+ All Ages 3.3 3.5 4.0 6.0 8.4 9.3 10.0 7.6 3.1 3.4 4.5 7.3 8.9 9.6 10.6 8.2 Leading Causes of Hospitalization: Pneumonia Septicaemia Enteric Diseases Top 5 Leading Causes of Hospitalization, Male, 2004-2008 16.2% 13.6% 12.5% 11.3% 53.4% 60.6% Viral infections of skin Influenza 2.0% 2.1% 1.7% 1.4%

Per 1,000 Population Pneumonia Enteric Diseases Septicaemia Top 5 Leading Causes of Hospitalization, Female, 2004-2008 53.0% 58.3% 16.0% 13.8% 15.5% 12.7% Viral infections of skin Influenza 2.2% 2.2% 1.8% 2.1% Ambulatory Rate of All Infectious Diseases 150 Ambulatory Rate of All Infectious Diseases, Both Male & Female, &, 2003-2006 100 50 0 <1 Year 01-04 05-09 10-19 65-74 75+ Total* S- Rate** 145.6 114.6 39.6 20.5 16.9 14.6 23.7 44.4 25.4 27.7 120.1 40.7 25.4 13.3 10.7 9.6 14.8 30.9 15.8 16.4 * The total is presented using the crude rate *S-Rate: Age-Standardized Mortality Rate

Leading Causes of Ambulatory ER Visits due to Infectious Disease Pneumonia Viral infections of Skin Enteric Diseases Leading Causes of Ambulatory Visits due to Infectious Disease, Male, 2003-2006 10.8% 8.4% 13.4% 12.9% 37.0% 37.1% Mycoses Influenza Chickenpox 4.7% 5.0% 3.9% 3.5% 2.9% 3.1% 0% 10% 20% 30% 40% Leading Causes of Ambulatory Visits due to Infectious Diseases, Female, 2003-2006 Pneumonia Viral infections of Skin Enteric Diseases Mycoses Influenza Chickenpox 13.9% 14.5% 11.0% 8.5% 6.2% 5.7% 4.2% 4.1% 2.4% 2.2% 32.6% 31.8% 0% 10% 20% 30% 40%

(Per 1,000 population) Per 1,000 Population 10-03. Infectious Disease Incidence Description Incidence Rate for All Infectious Diseases in Age Groups 10 8 6 4 2 0 0-9 Prevalence Rate of All Infectious diseases, area &, 2005-2009 10-19 years 65-74 75+ All Ages S-Rate* Male 4.4 2.7 4.9 2.6 2.2 2.6 3.6 3.9 Female 3.3 6.0 6.3 1.9 1.3 2.9 4.1 4.7 Male 3.2 6.5 7.6 2.4 2.1 4.3 5.0 5.3 Female 3.7 6.1 8.0 2.6 1.9 2.5 5.1 5.5 *S-Rate: Age-Standardized Mortality Rate 6 Age-Standardized Rate of All Infectious Diseases, 2005-2009 5 4 3 4.9 5.5 5.3 5.4 4.5 4.1 4.7 4.4 4.3 4.1 3.9 3.7 Male Female Both Source: integrated Public Health Information System ( iphis, 2009 )

Leading Causes of New Cases of Infectious Disease Sexually transmitted infections Top 5 Leading Causes of Infectious Diseases (New Cases), Male, 2005-2009 33.7% 58.3% Enteric zoonotic diseases 19.8% 25.6% Respiratory/infection control 7.2% 16.5% Bloodborne 6.1% 14.5% Vaccine preventable diseases 5.4% 4.7% 0% 20% 40% 60% Sexually transmitted infections Enteric zoonotic diseases Top 5 Leading Causes of Infectious Diseases (New Cases), Female, 2005-2009 20.2% 19.7% 48.3% 57.1% Respiratory/infection control 6.8% 14.9% Bloodborne Vaccine preventable diseases 7.8% 6.6% 5.1% 4.6% 0% 20% 40% 60%

The Proportion of infectious diseases in Each Group: Bloodborne/Sexually Transmitted Infections, 2005-2009 N % N % Chlamydia 1146 72.1% 121994 71.9% Hepatitis B,C,D 313 19.7% 18028 10.6% Gonorrhoea (all types) 72 4.5% 18421 10.9% Syphilis 36 2.3% 7839 4.6% HIV/AIDS 21 1.3% 3018 1.8% Other 2 0.1% 310 0.2% Total 1590 100% 169610 100% Enteric Zoonotic Diseases, 2005-2009 N % N % Campylobacter Enteritis 314 45.8% 18297 35.5% Salmonellosis 153 22.3% 12717 24.7% Giardiasis 70 10.2% 7700 15.0% Cryptosporidiosis 47 6.9% 1687 3.3% E. Coli 20 2.9% 1321 2.6% Other 81 11.8% 9753 18.9% Total 685 100% 51475 100% Vaccine Preventable Diseases, 2005-2009 N % N % Streptococcus Pneumoniae 65 45.8% 5048 37.3% Meningitis 36 25.4% 1734 12.8% Pertussis 14 9.9% 4037 29.9% Mumps 8 5.6% 494 3.7% Chickenpox 7 4.9% 809 6.0% Meningococcal disease 7 4.9% 290 2.1% Other 5 3.5% 1104 8.2% Total 142 100% 13516 100%

10-04. Childhood Vaccination Coverage Description Percentage of School Children With Up-to-Date Vaccines: Daycare Nurseries Primary Schools Secondary Schools Vaccine Haemophilus-B Diphtheria, Tetanus and Pertussis Measles, Mumps and Rubella (MMR) Polio IPV/OPV DPT-P and MMR Meningitis-C DPT-P and MMR Meningitis-C 2007 2008 2009 65% 62% 68% 63% 64% 66% 82% 86% 87% 59% 64% 70% 80% 83% 84% 91% 77% 79% 90% 84% 83% 72% 73% 79% Source: : Vaccine Preventable Diseases Annual Report 2009 Proportion of Grade 7 Students Who are Up-to-Date with the Hepatitis B Program 2008 2009 1st dose 2nd dose Hepatitis B 78% 78% Source: : Vaccine Preventable Diseases Annual Report 2009 Proportion of Grade 8 Students (females only) Up-to-Date with HPV Vaccination HPV vaccine 2008 2009 1st dose 57.6% 75.0% 2nd dose 55.7% 74.2% 3rd dose 54.1% 73.7% Source: : Vaccine Preventable Diseases Annual Report 2009 10-05. Influenza and Pneumococcal Vaccination Rates Among Long-Term Care Facility Residents Description Influenza Immunization Coverage of Residents Residents Seasonal Influenza H1N1 2009 93% 83% Source: : Vaccine Preventable Diseases Annual Report 2009

10-06. Influenza Vaccination Rates Among Staff at Long- Term Care Facilities and Hospitals Description Influenza Immunization Coverage of Staff Staff Nursing Homes / Residential Facilities Hospitals Seasonal Influenza H1N1 32% 45% 16% 80% Source: : Vaccine Preventable Diseases Annual Report 2009 10-07. Influenza Vaccination Description Influenza Vaccination Coverage Without a Chronic Condition* With a Chronic Condition* 2001 2003 2005 2007 12-64 24.4% 30.4% 33.8% 29.8% 65+ 59.9% 61.5% 75.4% 54.5% All Ages 27.7% 33.5% 38.7% 32.6% 12-64 25.1% 25.6% 34.0% 27.8% 65+ 63.5% 65.8% 70.0% 65.6% All Ages 28.9% 29.7% 37.7% 31.7% 12-64 38.9% 55.2% 52.2% 56.1% 65+ 73.9% 74.9% 81.2% 77.3% All Ages 49.7% 61.0% 59.6% 62.2% 12-64 41.3% 43.6% 49.1% 43.2% 65+ 73.4% 73.4% 75.8% 73.6% All Ages 51.4% 52.8% 57.5% 53.1% *: Chronic Conditions include: Asthma, Emphysema/COPD, Heart Disease, Chronic Bronchitis, Diabetes, Cancer, Stroke Source: Canadian Community Health Survey (CCHS), Cycle 1.1-4.1, weighted data 10-08. Adverse Events Following Immunization Description Adverse vaccine event in 2006~2009 (Times): Male Female Both Male Female Both 2006 3 8 11 125 54 179 2007 3 7 10 204 104 308 2008 4 8 12 98 204 302 2009* 13 30 43 376 882 1261 *: includes the heightened surveillance and reporting of adverse vaccine events surrounding the H1N1 vaccination

Per 1,000 Population 10-09. Animal Rabies Description Animals Testing Positive (#) Post- Exposure Vaccinatio n of Exposed Cases (%) Rabies- Related Human Deaths Year 2009 0 13.0 0 2008 0 6.7 0 2007 0 11.2 0 2006 0 4.3 0 2005 2 3.3 0 2004 0 2.9 0 2003 2 4.4 0 2002 3 8.4 0 2001 1 4.4 0 Source: Internal Data, 10-10. Pelvic Inflammatory Disease Description Age-Specific Rate of Ambulatory ER Visits due to Pelvic Inflammatory Disease 4 Age-Specific Rate of Ambulatory ER Visits due to Pelvic Inflammatory Disease, area &, 2003-2006 3 2 1 0 01-09 10-19 65+ All Ages S-Rate* 1.3 1.9 3.4 1.3 1.1 2.1 2.4 0.6 1.5 2.6 0.9 0.4 1.4 1.6 *S-Rate: Age-Standardized Mortality Rate

Per 1,000 population Age-Specific Hospitalization Rate due to Pelvic Inflammatory Disease 0.5 Age-Specific Rate of Hospitalization due to Pelvic Inflammatory Disease, area &, 2004-2008 0.4 0.3 0.2 0.1 0.0 00-09 10-19 years 65+ All Ages S-Rate*.04.04.38.19.00.18.21.01.12.35.19.05.20.21 *S-Rate: Age-Standardized Mortality Rate